24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2022
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2022 VC Survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Quris
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
15:16
"We see the biggest opportunities in residential construction"
15:05
"Our goal is to produce clean, affordable energy that supports the economy"
14:52
Once $5 billion IPO bound, Cybereason merges with Trustwave amid decline
12:59
"We’re effectively democratizing access to computing power through our platform"
More stories
Buzz
Most popular
Daily
Weekly
1
Oracle CEO: "If we continue on our current trajectory, reaching a valuation of a trillion dollars is inevitable"
2
Is your solitaire opponent actually a bot?
3
Cloudera acquires Israeli startup Octopai to advance metadata and AI integration
4
Former Snyk founder Guy Podjarny secures $125M for AI-powered software startup Tessl
5
CyberArk and Wiz join forces to enhance cloud security in multi-cloud environments
More news
Quris
7 stories about Quris
Quris-AI appoints Michel Vounatsos and Yossi Ben Amram in key roles
04.01.24
|
CTech
Vounatsos was appointed Board member and Ben Amram was appointed President, respectively.
Pharma giant Merck expands collaboration with Quris-AI
28.09.23
|
Meir Orbach
This follows the successful initial collaboration, a preclinical study to assess Quris-AI’s ability to predict drug toxicity in comparison to traditional in vitro and in vivo approaches
SoftBank leads $9 million investment in AI pharma startup Quris
20.12.22
|
Meir Orbach
The Israeli startup expanded its Seed funding to $37 million and plans to use the additional investment to advance its Bio-AI clinical-prediction platform that simulates clinical trials
CTech’s Book Review: Breaking down the barriers to set you free
13.07.22
|
Isaac Bentwich
Isaac Bentwich, Founder and CEO of Quris Technologies, shares insights after reading “Untethered Soul” by Michael A. Singer
Pharma giant Merck inks deal with Israel’s Quris for clinical safety prediction
09.02.22
|
Meir Orbach
The Israeli company which develops predictive technology based on artificial intelligence has signed an agreement worth tens of millions of dollars to test drugs by the pharma giant
Quris closes record $28 million Seed funding for AI drug development platform
11.01.22
|
Meir Orbach
The Israeli startup uses AI-powered miniaturized “patients-on-a-chip” to avoid the risks and costs of failed clinical trials and eliminate the reliance on ineffective animal testing
Quris raises $9 million in Seed for its clinician prediction AI platform
21.10.21
|
James Spiro
The announcement coincides with the launch of its platform via a partnership with the NYSCF Research Institute.
Please ensure Javascript is enabled for purposes of
website accessibility